Exploring Gastrointestinal Symptoms And Their Impact on Quality of Life in Patients with Neuroendocrine Tumours

#1470

Introduction: Treatments in NETs have been studied for effects on tumour progression and carcinoid syndrome with minimal evidence on gastrointestinal(GI) symptom burden and impact on quality of life(QoL)

Aim(s): To determine whether patients with NETs receiving treatment experience GI symptoms, and to explore their impact on QoL

Materials and methods: A prospective cohort of 46 patients with histologically confirmed NET visiting endocrine and oncology clinics completed GSRS(gastrointestinal symptom rating scale) and EORTC QLQ-GINET21 QoL questionnaires prior to establishment of a gastroenterology NET service

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Williams M, Reid K, Ng S, Benny A, Lewis J,

Keywords: Quality of life, symptoms,